Position
Squarepoint Ops LLC in Immix Biopharma, Inc.
Back to the book · All holders of IMMX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $83.4K$5.23 → $9.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 21.5K | $112.4K | — | — | — | 0.0% |
| Q1 2026 | 44.5K | $405.3K | $9.11 | $83.4K | $209.4K | 0.0% |